e-learning
resources
ERJ
2003
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other?
Marchand E., Etienne-Mastroian... B., Chanez P., Lauque D., Leclerc P., Cordier J.F., Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERMOP)
Source:
Eur Respir J 2003; 22: 8-13
Journal Issue:
July
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marchand E., Etienne-Mastroian... B., Chanez P., Lauque D., Leclerc P., Cordier J.F., Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERMOP). Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other?. Eur Respir J 2003; 22: 8-13
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia
Source: Eur Respir J 2013; 41: 402-409
Year: 2013
Idiopathic acute and chronic eosinophilic pneumonia
Source: Annual Congress 2009 - Update on eosinophilic lung diseases
Year: 2009
Manifestation of idiopathic chronic eosinophilic pneumonia
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009
Diffuse idiopathic pulmonary neuroendocrine hyperplasia, chronic eosinophilic pneumonia, and asthma
Source: Eur Respir J 2009; 34: 1489-1492
Year: 2009
A study on the pulmonary function of patients with chronic eosinophilic pneumonia
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Asthma and chronic idiopathic eosinophilic pneumonia (CIEP): a study of 52 patients
Source: Eur Respir J 2001; 18: Suppl. 33, 5s
Year: 2001
Clinical implication of interleukin-33 in acute eosinophilic pneumonia compared with chronic eosinophilic pneumonia
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011
Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia.
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
A clinical study of chronic eosinophilic pneumonia (CEP)
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009
Late-onset persistent eosinophilic severe asthma
Source: International Congress 2015 – Severe asthma phenotyping
Year: 2015
Eosinophilic refractory inflammation in OCS-dependent severe asthma
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Hypereosinophilic obliterative bronchiolitis: a distinct, unrecognised syndrome
Source: Eur Respir J 2013; 41: 1126-1134
Year: 2013
The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008
Asthma exacerbations and eosinophilic inflammation 6 months after treatment with mepolizumab in refractory eosinophilic asthma
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Benralizumab for severe asthma associated with extra-airway eosinophilic diseases
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema
Source: Eur Respir J 2001; 17: 596-603
Year: 2001
Development of chronic airway obstructive in patients with eosinophilic bronchitis: a prospective follow up study
Source: Eur Respir J 2003; 22: Suppl. 45, 423s
Year: 2003
Inflammatory markers during bronchiolitis, relation to persistent asthma?
Source: Annual Congress 2010 - Risk factors for allergic diseases in children
Year: 2010
Causes of chronic cough in patients with interstitial pneumonia
Source: Annual Congress 2008 - Lung function, airways and cough
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept